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Appropriate reference intervals are essential when using laboratory test results to guide medical 
decisions. Conventional approaches for the establishment of reference intervals rely on large samples 
from healthy and homogenous reference populations. However, this approach is associated with 
substantial financial and logistic challenges, subject to ethical restrictions in children, and limited in 
older individuals due to the high prevalence of chronic morbidities and medication. We implemented 
an indirect method for reference interval estimation, which uses mixed physiological and abnormal 
test results from clinical information systems, to overcome these restrictions. The algorithm minimizes 
the difference between an estimated parametrical distribution and a truncated part of the observed 
distribution, specifically, the Kolmogorov-Smirnov-distance between a hypothetical Gaussian 
distribution and the observed distribution of test results after Box-Cox-transformation. Simulations of 
common laboratory tests with increasing proportions of abnormal test results show reliable reference 
interval estimations even in challenging simulation scenarios, when <20% test results are abnormal. 
Additionally, reference intervals generated using samples from a university hospital’s laboratory 
information system, with a gradually increasing proportion of abnormal test results remained stable, 
even if samples from units with a substantial prevalence of pathologies were included. A high-
performance open-source c++ implementation is available at https://gitlab.miracum.org/kosmic.
Laboratory test results need to be accompanied by appropriate reference intervals to support clinical 
decision-making1,2. Conventional protocols for the establishment of reference intervals (“direct methods”) 
require the sampling of a carefully selected, sufficiently large (usually >120 individuals), and homogenous group 
of healthy reference individuals, and the 2.5th and 97.5th percentiles of test results define the reference interval3–5. 
However, this approach is associated with substantial financial and logistic challenges, subject to considerable 
ethical restrictions in pediatrics, and limited in older age groups due to the high prevalence of chronic morbidities 
and medication5,6. Additionally, the use of direct methods results in substantial differences between the reference 
population and the target population in which the reference intervals are eventually used. Most patients are 
significantly older, use prescription drugs, and have relevant co-morbidities1. This results in uncertainty regard-
ing the suitability of reference intervals based on blood samples from young and healthy adults, and limits the 
creation of accurate reference intervals for children and elderly adults. Importantly, many reference intervals 
for laboratory tests in children established using direct methods do not appropriately account for the extensive 
changes with age. Furthermore, use of conventional reference interval methods often results in inacceptable wide 
confidence intervals, particularly when non-normal distributions of test results are analyzed, e.g. analytes follow-
ing a log-normal distribution7.
Indirect methods use data from laboratory information systems, which contain both physiological and abnor-
mal test results, to overcome the restrictions mentioned above7–9. The basic assumption underlying these methods 
is that the majority of test results obtained during routine patient care are physiological, and can therefore be used 
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to derive reference intervals9. To accomplish this, the proportion of physiological samples in the mixed input 
dataset is identified using different sophisticated statistical methods. As large numbers of test results are readily 
available from laboratory information systems, this enables the establishment of reference intervals specific to 
different populations, age-groups, analytical devices, and even batches and reagents. Extensive experience with 
these methods exists in children, where unique ethical challenges limit access to blood samples to create reference 
intervals8,10–12 and in challenging adult populations with a high proportion of patients with substantial morbidity 
and mortality13.
A variety of indirect methods have been implemented5, including the well-known Hoffmann approach14 and 
the Bhattacharya method15. However, both of these methods assume a Gaussian distribution of physiological 
test results, and require visual identification of a proportion of purely physiological test results, a process which 
is prone to bias and prevents integration into automated pipelines. Recently, a method developed by Arzideh 
et al.9,16–19 has been used to establish reference intervals for adults13 and children8,10–12,20. This method uses a 
truncation interval of the range of test results in the input dataset after Box-Cox transformation to estimate a 
distribution of supposedly physiological test results, and can therefore estimate non-Gaussian distributions. The 
truncation interval, the Box-Cox transformation parameter λ, and the parameters of the Gaussian distribution µ 
and σ are estimated using an elaborate statistical process, which is implemented within a freely available software 
package (https://www.dgkl.de/verbandsarbeit/arbeitsgruppen/entscheidungsgrenzen-richtwerte/). However, 
implementation using both Microsoft Excel and the R software environment requires human interaction and 
prevents integration into analysis pipelines, leads to technical difficulties, poor performance (reference interval 
estimation can take minutes), and the resulting lack of confidence intervals limits more widespread use and 
enhancement of this approach. Additionally, the statistical approach has evolved over time, and a complete and 
succinct description of the currently distributed algorithm has not been published, as has an in-depth evaluation 
of the method’s performance in terms of validity of the generated reference intervals.
As part of the PEDREF study (Next-Generation Pediatric Reference Intervals, www.pedref.org), in which 
pediatric reference intervals are established using data mining, we have created a high-performance implementa-
tion which uses an enhanced statistical approach. The developed application can be integrated into analysis pipe-
lines and frameworks and provides confidence intervals for the estimated reference intervals. Here, we present 
the used algorithm, and evaluate the accuracy of the calculated reference intervals using both simulated datasets 
and patient samples. To facilitate evaluation of the algorithm, a web-based application allows analysis of datasets 
without local installation of the provided tools.
Methods
We employ an approach based on previous works by Arzideh et al.9,16–19 and our experiences in their application 
to pediatric and adult datasets8,10–13: This procedure is based on the assumption that the proportion of physiologi-
cal samples in the input dataset can be modeled with a parametric distribution (so-called Power Normal distribu-
tion, a Gaussian distribution after Box-Cox transformation of the data, i.e. a distribution that can accommodate 
skewed data), and that a truncation interval T exists within the dataset, in which the proportion of abnormal 
test results is negligible. Importantly, no assumptions regarding the distribution of pathologic samples are made.
The algorithm minimizes the Kolmogorov-Smirnov distance between an estimated normal distribution F 
and a truncated part of the observed distribution of test results after Box-Cox-transformation D (Fig. 1)21,22. This 
accounts for the fact that the majority of physiological biological distributions can be described using Gaussian 
distributions, Log-Normal distributions, or Gaussian distributions after Box-Cox transformation23, and that 
the Kolmogorov-Smirnov test is an established test for normality. The parameters of the normal distribution 
(µ, σ), the Box-Cox-transformation parameter (λ), and the truncation interval T are optimized numerically24. 
Specifically, the following term KS is minimized within the truncation interval T:
=
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outside the truncation interval T (p1 is calculated for values below T, p2 is calculated for values greater T, p1 or p2 
are ignored if either is <0).
In practice, the following steps are performed in a nested manner (Fig. 1):
 1. Optimization of λ (this is done using iterative “Brute Force search” optimization, i.e. every λ in 0, 0.1, 0.2, 
…, 1.0 is tried, followed by λ − 0.09, λ − 0.08, …, λ + 0.09, restricted to [0.0 to 1.0]).
 2. Optimization of µ and σ using Downhill-Simplex/Nelder-Mead optimization.
 3. Optimization of the truncation interval T (“Brute Force search” optimization, i.e. every possible combi-
nation of the lower truncation limit T1 and upper truncation limit T2 [within bounds specified as input 
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Figure 1. Estimation of reference intervals in a “contaminated” dataset. Based on the histogram of test results, 
the cumulative density (cumulative histogram) of test results D is calculated. After that, the cumulative density 
F of a parametrical function (a normal distribution described by µ and σ) is compared to D inside a truncation 
interval T, specifically, the maximum distance on the y-axis between F and D. Using an optimization process, 
T and the parameters µ and σ resulting in the minimum sup |D-F|/√n + p are identified (n denotes the number 
of samples inside the truncation interval, p denotes a penalty term, see Methods for details), which can be used 
to construct the estimated distribution of physiological test results. To enable the estimation of non-normal 
distributions, this process is performed for different “skewness” factors λ, which are applied beforehand (Box-
Cox transformation using λ), and the λ resulting in the minimum optimization term KS is ultimately used.
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parameters, by default the 5th to 30th percentile, and 70th to 95th percentile of the input dataset, respectively] 
is examined).
 4. Calculation of the optimization target (minimization target) KS.
We selected “Brute Force search” optimization for steps 1 and 3, as unpredictable local minima prevent 
the use of other minimization techniques. To provide confidence intervals, we use bootstrapping of the input 
dataset (random sampling with replacement). A high-performance open source C++-implementation of the 
outlined algorithm is available as part of the PEDREF study (Next-Generation Pediatric Reference Intervals, 
Kolmogorov-Smirnov based reference intervals, kosmic at https://gitlab.miracum.org/kosmic). The application 
is small (<1 MB binary), portable (compiles under Windows and Linux without external dependencies) and 
uses multi-threading for optimum performance on modern computers. Python bindings (Python Software 
Foundation, https://www.python.org/) enable integration of kosmic as a binary library into custom analysis pipe-
lines, and a web-based tool available at https://kosmic.diz.uk-erlangen.de/ enables use of the presented applica-
tion without local installation.
To evaluate the algorithm’s performance in terms of the correctness of the generated reference intervals, we 
assessed the impact of abnormal samples on reference interval estimations using simulated datasets (“hemoglo-
bin”, “Thyroid-stimulating hormone, TSH”, and “Gamma-glutamyltransferase, γ-GT”). We generated random 
distributions of physiological test results corresponding to typical adults’ reference intervals (“hemoglobin”: 
Gaussian distribution, μphysiological = 14.0 and σphysiological = 0.98 corresponding to a reference intervals from 12.0–
16.0 “g/dL”; “TSH”: Log-Normal distribution, reference interval 0.25-4.0 “U/l”; “γ-GT”: Log-Normal distribution, 
reference interval 10–50 “U/l”). Sets of “abnormal” samples were added (“hemoglobin”: Gaussian distribution, 
varying μabnormal and σabnormal; “TSH”: varying Gaussian distributions; “γ-GT”: varying Log-Normal distribu-
tions) while the total number of samples in the dataset was not varied (“hemoglobin”: ntotal = 10,000; “TSH”: 
ntotal = 50,000; “y-GT”: ntotal = 25,000): We changed the ratio of “abnormal” samples (0%–30%) and the position 
of the distribution of “abnormal” samples. These steps were performed for n=100 cycles, and median estimated 
upper and lower reference limits are reported, as are the 90% confidence intervals of estimated upper and lower 
reference limits.
Similarly, we examined the influence of abnormal test results on reference intervals in a patient dataset from 
a tertiary care center (University Hospital Erlangen, Germany): We retrieved laboratory test results from patients 
aged 18–60 years from the laboratory information system (inpatients and outpatients from all units, including test 
results from specialty units and intensive care units). (Analysis of test results performed during patient care for 
research is in accordance with the applicable German/Bavarian regulations and does not require patients’ explicit 
consent. Use of pediatric and adult patient datasets in the PEDREF study has been approved by the Ethical Review 
Boards of the University Hospital Erlangen, reference number 97_17 Bc.) Test results were then categorized in 
groups according to the prevalence of abnormal samples in the requesting unit (A, B, C, D, with an increasing 
proportion of abnormal test results, see Table 1), and these groups were combined for further analyses (e.g. group 
AB contains test results from groups A and B). Only one randomly selected sample per patient was examined 
when estimating reference intervals, based on previous examinations, which showed no difference between a 
random sample and more selective sample selection approaches13. The patient population in the examined dataset 
consists mainly of Caucasian individuals and we did not stratify according to ethnicity.
Results
We provide a high-performance and open source implementation of an indirect method for reference interval 
estimation (https://gitlab.miracum.org/kosmic). Reference intervals can be calculated quickly, e.g. <50 ms using 
a typical dataset of hemoglobin test results without confidence intervals, and <3 s with confidence intervals using 
bootstrapping (n=100) on a typical personal computer. Importantly, the tool can be integrated into custom pipe-
lines using a command line interface or using Python bindings on different computing platforms. For evaluation 
purposes, we provide a web-based application (https://kosmic.diz.uk-erlangen.de/), which enables use of kosmic 
without local installation.
Evaluations of the provided tool using simulated scenarios of common biological analytes with increasing 
proportions of abnormal test results and varying overlap of physiological and abnormal distributions are shown 
in Fig. 2 and Supplemental Tables 1–3. Simulated “hemoglobin” reference intervals (Fig. 2, Supplemental Table 1) 
show the relationship of generated reference intervals, position of abnormal test results, and ratio of abnor-
mal and physiological test results, and the width of reference intervals’ confidence intervals. Importantly, most 
Group
Estimated Probability of blood 
count abnormalities Patient group Samples Patients
A Very low, comparable to the general population Hospital staff occupational health check-ups 15503 15493
B Low Endocrinology, Cardiology, Nuclear medicine 11872 5894
C Intermediate Remaining units, mainly internal medicine, including ERs 89171 20427
D Very high Oncology/hematology, radiation therapy, ICUs 81649 5932
Table 1. Patient samples categorized according to the estimated probability of blood count abnormalities. 
Samples and patients columns show the median number of samples and patients per analyte in each group used 
for reference interval estimation (18–60 years). ER, emergency room; ICU, intensive care unit.
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estimated reference limits (74%, Supplemental Table 1) are within narrow limits (11.8-12.2 and 15.8-16.2 “g/dL”) 
of the true reference limits (12.0 and 16.0 “g/dL”). In scenarios with the most overlap between physiological and 
abnormal test results (i.e. when the abnormal distributions are “centered” on the true lower or upper reference 
limit), estimations are most challenging, resulting in an increasing deviation of estimated and true reference 
limits, especially when the proportion of abnormal values is ≥20%. On the other hand, reference limit estima-
tions are reliable even in challenging settings (up to 30% abnormal test results on either side), when the overlap 
between abnormal and physiological test results is low. When assessing the differences between estimated and 
true reference limits separately for lower and upper reference limits, differences in estimated and true reference 
intervals are more pronounced in upper reference limits.
Simulated scenarios of analytes that can be described using a Log-Normal distributions are shown in 
Supplemental Tables 2 and 3. Results in these simulations are in line with the “hemoglobin” results, specifically, 
a high proportion of reference limits within narrow limits (81.1% of “TSH” reference limits within 0.2–0.3 and 
3.8–4.2 “mU/L”, and 65.9% of “γ-GT” reference limits within 8–12 and 48–52 “IU/L”), with more differences 
between true reference limits and estimated limits for the upper than the lower reference limit. Similarly, most 
estimated reference limits are within the specified margins when <20% of samples are abnormal, depending on 
the overlap between physiological and abnormal samples. Interestingly, upper reference limits for “γ-GT” are 
more often estimated too low rather than too high in comparison to “hemoglobin” and “TSH” reference intervals. 
(The abnormal samples for “γ-GT” are simulated using a Log-Normal distribution, while a Gaussian distribution 
was used for “hemoglobin” and “TSH”).
Reference intervals for 3 different common laboratory tests (hemoglobin, white cell count, and platelets) and 
associated 90% confidence intervals generated using samples from a tertiary care center’s laboratory information 
system are shown in Fig. 3. These results show a minor widening in reference intervals with an increasing propor-
tion of abnormal test results, most pronounced in white cell count upper reference limits and least pronounced 
in platelet upper reference limits. Importantly, changes in reference intervals between groups A, AB, ABC, and 
ABCD are minor, although a substantial proportion of abnormal samples is included in datasets ABC and ABCD, 
Figure 2. Influence of abnormal test results on estimated “hemoglobin” reference intervals. Reference intervals 
(dashed lines) and 90% confidence intervals (gray areas) for simulated “hemoglobin” datasets (true reference 
interval 12.0–16.0 “g/dL”) with different proportions of abnormal “hemoglobin” test results. The center-top 
panel shows the influence of the proportion of abnormal test results (95% interval of abnormal “hemoglobin” 
values 8.0–12.0 “g/dL”, ntotal = 10,000) on estimated lower reference limits, the center-right panel shows the 
influence of the position of abnormal test results (20% abnormal “hemoglobin” values, 95% range 4.0 “g/dL”, 
ntotal = 10,000). The bottom table shows “hemoglobin” reference intervals and confidence intervals when both 
abnormally high and low values are contained in the dataset (ntotal = 10,000). (Supplemental Table 1 shows 
combinations of other abnormal “hemoglobin” distributions, and Supplemental Tables 2 and 3 show reference 
intervals for simulated “Thyroid-stimulating hormone, TSH”, and “Gamma-glutamyltransferase, γ-GT” test 
results).
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specifically patients from emergency rooms, oncology, and intensive care units – in these patients a substantial 
prevalence of anemia (low hemoglobin concentrations), leukocytosis (high white cell counts) and leukopenia 
(low white cell counts), and thrombocytopenia (low platelet counts) has to be considered. Even when removing 
patient samples with a relatively low proportion of abnormal samples (i.e. groups A and/or B), reference intervals 
for hemoglobin and platelets remain relatively stable, whereas white cell counts upper reference limits show sub-
stantial changes in these settings.
Discussion
For clinical laboratories, establishment and validation of reference intervals are essential tasks and partition of 
reference intervals by covariates, most importantly age and sex, is of major clinical importance. Direct approaches 
to reference interval calculation require recruitment of adequately sized healthy cohorts which account for all 
relevant covariates – a challenge which is often unmet, especially when individual laboratories establish reference 
intervals. Indirect approaches use samples from patient care for reference interval estimation, and are therefore 
unrestricted by ethical, practical, and financial limitations due to the need for sample acquisition.
We provide a high-performance and open source implementation of an indirect method for reference inter-
val estimation. In contrast to previous implementations, which used both Microsoft Excel and R and therefore 
required human interaction, this enables integration into analysis frameworks. Additionally, we opted to provide 
kosmic under an open-source license (“GNU General Public License, Version 3.0”), which facilitates peer review 
of the implementation and enhancement of our approach – a process we greatly welcome. Implementation using 
C++ enables creation of dependency-free executables for different computing platforms, which simplifies distri-
bution and mitigates technical difficulties. Device manufacturers can integrate kosmic into laboratory information 
systems and laboratory analyzers, to provide indirect methods for reference interval calculation as a complement 
to direct approaches. More importantly, the increased run-time performance enables the calculation of confi-
dence intervals using bootstrapping.
Stratification of reference intervals by clinically relevant covariates requires a quantitative measure of reference 
interval precision, e.g. confidence intervals. Availability of confidence intervals for reference intervals in the pro-
vided implementation is therefore a marked improvement to previous implementations, and enables application 
of this indirect method to a broader field of clinical and scientific areas and questions. The possibility to integrate 
the algorithm into analytical frameworks is of major importance for comprehensive studies. In the PEDREF 
study, pediatric reference intervals are represented using continuous reference intervals and percentile charts, 
resulting in a separate reference interval for each day of life. To this end, hundreds of discrete reference intervals 
are estimated and joined using spline curves, an approach which requires embedding of the statistical algorithm. 
This is greatly facilitated by the availability of kosmic as a non-dependency executable and as a Python library. 
Importantly, this also simplifies replication and validation of results between different studies.
The reference intervals established with kosmic are reliable even in challenging simulation settings (i.e. when 
the distributions of abnormal test results are centered on the 2.5th and 97.5th percentiles of the distribution of 
physiological test results) when <20% test results are abnormal (Fig. 2, Supplemental Tables 1–3). When using 
patient samples, estimated hemoglobin, platelet count, and white cell count reference intervals were stable, even 
if patients from intensive care units and hematology/oncology are included (Fig. 3). Hemoglobin and platelet 
count reference intervals remained stable, even if samples from units with a low proportion of abnormal test 
results were removed and only samples from units with a substantial prevalence of pathologies remained (e.g. 
emergency and intensive care, hematology/oncology), while estimation of appropriate white cell count reference 
intervals depended on the presence of a relatively healthy patient group. The latter finding is probably due to the 
unspecific nature of leukocytosis, which can be caused e.g. by infection, inflammation due to other causes, and 
malignant diseases, but also by stress – a very common finding in a hospital population. (One could possibly 
argue that mild leukocytosis <13,000/µl is so unspecific in a hospital setting, that it can be considered essentially 
non-diagnostic – or “normal”.) Overall, these results confirm the basic assumption of indirect methods (correct 
Figure 3. Estimated reference limits in different analytes and patient groups. Reference intervals and 
confidence intervals for hemoglobin concentration, white cell count, and platelet count in women were 
determined using different patient groups with an increasing proportion of pathologic samples (e.g. Group A: 
check-up visits only, Group D: hematology/oncology patients only, see Table 1 for full group descriptions). ▲ 
denote the 2.5th percentiles, ■ denote the 50th percentiles, and ▼ denote the 97.5th percentiles, bars denote the 
respective 90% confidence intervals.
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identification of the proportion of physiological test results in a mixed dataset is possible), and the suitability of 
the statistical approach used to this end in kosmic (optimization of truncation points and a Gaussian distribution 
after Box-Cox-transformation using the Kolmogorov-Smirnoff distance) in a wide range of clinical scenarios.
Both simulated datasets and patient datasets show a more pronounced volatility of upper reference limits in 
comparison to lower limits. This is mainly caused by the assumptions underlying the statistical algorithm: the 
Box-Cox transformation parameter λ is optimized in the range [0, 1], resulting in distributions ranging from a 
symmetrical Gaussian (λ = 1) to a right-skewed Log-Normal (λ = 0) distribution. Depending on the input data-
set, the algorithm therefore models the distribution of supposedly physiological test results with a right-skewed 
Log-Normal distribution, while a left-skewed distribution would be outside the specified parameter bounds. A 
mixture of two overlapping Gaussian distributions, with a major physiological part on the “left” and a minor 
abnormal part on the “right” results in a “Log-Normal-like” distribution, explaining the more pronounced diffi-
culty of the algorithm in separating abnormally high and physiological test results in comparison to abnormally 
low test results.
The presented evaluations of kosmic using simulations and real-world datasets enable assessment of the algo-
rithm’s applicability for different clinical and scientific scenarios, in contrast to other indirect approaches for 
reference interval estimation, where the performance in terms of reference interval accuracy has been less inten-
sively studied. Importantly, this can be used to guide preprocessing of the input dataset, e.g. using filters (“remove 
patients from intensive care units”, “remove all patients with multiple hospitalizations”, “remove all patients with 
repeat measurements”) to reduce the proportion of patients with a high proportion of abnormal test results. Based 
on the results from our simulations and patient datasets, we recommend a proportion of less than 20% abnormal 
test results. Our results in patient datasets demonstrate that this does not necessarily require removal of patients 
even with a very high proportion of abnormal test results (e.g. patients from intensive care units). However, if 
removal of samples using meta-information e.g. regarding intensive care treatment or clinical information is 
feasible, this can certainly improve the accuracy of reference intervals.
Limitations
kosmic can be used to establish reference intervals for homogenous populations. While this is an important clini-
cal and scientific application, e.g. to create sex-specific reference intervals for homogeneous age groups (i.e. strati-
fication using categorical features), many covariates change continuously. Specifically, we have shown continuous 
change with age of reference intervals in children and argued for a corresponding representation8,10–12 – however, 
establishment of continuous reference intervals, even with kosmic, currently requires a two-step process, in which 
reference intervals are first established for discrete age groups and then fused to create a continuous representa-
tion. We are currently exploring integration of nominal covariates into the algorithm, and availability of kosmic 
as open source software also enables other groups to improve our approach with regard to covariates or other 
features. Additionally, while we have greatly improved the run-time performance of the algorithm in comparison 
to previous implementations, some dataset characteristics can negatively impact run time. In particular, the time 
needed to identify the best truncation interval using a “Brute Force” approach depends on the number of possible 
combinations of upper and lower truncation points in the truncation interval search area (i.e. 5th to 30th and 70th 
to 95th percentile by default) – under unfavorable conditions (depending on the number of decimal digits and the 
shape of the input distribution), this can still result in long run times.
conclusions
kosmic enables accurate reference interval estimation using patient samples retrieved from laboratory informa-
tion systems. This facilitates more widespread application of indirect approaches for reference interval calcula-
tion, with the ultimate aim to increase the value of laboratory testing for clinical decision-making.
Data availability
An open-source (GPL 3) C++ implementation and windows builds of the presented algorithm are available at 
https://gitlab.miracum.org/kosmic, the simulation datasets are available at https://gitlab.miracum.org/kosmic/
benchmarks. A web-based application for evaluation purposes is available at https://kosmic.diz.uk-erlangen.de/. 
The patient datasets analyzed in the present report (Fig. 3) were used with permission from Prof. S.W. Krause 
(Department of Medicine 5 - Haematology and Oncology, University Hospital Erlangen, Erlangen, Germany) 
and are not publicly available. Data are however available from the authors upon reasonable request and with 
permission from Prof. S.W. Krause.
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